MIRA
INFORM REPORT
|
Report Date : |
20.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
MANKIND PHARMA LIMITED |
|
|
|
|
Formerly Known
As : |
MANKIND PHARMA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
236, Okhla Industrial Estate, Phase – 111, New Delhi – 110020 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
03.07.1991 |
|
|
|
|
Com. Reg. No.: |
55-044843 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 200.294
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74899DL1991PLC044843 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELM09991C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACM9401C |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Trader of Pharmaceutical and Health Care Products. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
A (67) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 36800000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and a reputed company having fine track
record. Financial position of the company appears be sound. Fundamentals are
strong and healthy. Trade relations are reported as fair. Business is active.
Payments are reported to be regular and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered / Corporate Office : |
236, Okhla Industrial Estate, Phase – 111, New Delhi – 110020, India |
|
Tel. No.: |
91-11-46541400 (30 Lines) |
|
Fax No.: |
91-11-46541382 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head Office : |
6-B, Mohakampur Enclave, |
|
|
|
|
Factory 1 : |
Poanta Sahib (Himachal Pradesh), |
|
|
|
|
Factory 2 : |
Udyog Vihar. 485 and 490, Phase 5, Gurgaon, Haryana, India |
|
|
|
|
Branch Offices : |
Located at Ř
Meerut Ř
Secunderabad Ř
Indore |
DIRECTORS
AS ON 29.09.2012
|
Name : |
Mr. Ramesh Chand Juneja |
|
Designation : |
Managing director |
|
Address : |
7, Vasant Marg, 2nd Floor, Vasant Vihar, New Delhi -
110057, India |
|
Date of Birth/Age : |
18.07.1950 |
|
Date of Appointment : |
03.07.1991 |
|
PAN No.: |
AEJPJ9773L |
|
DIN No.: |
00283399 |
|
|
|
|
Name : |
Mr. Rajeev Juneja |
|
Designation : |
Whole-time director |
|
Address : |
F-42, Radhey
Mohan Drive,
Jonapur, Mehrauli, New Delhi, India |
|
Date of Birth/Age : |
28.07.1965 |
|
Date of Appointment : |
22.12.1992 |
|
PAN No.: |
ADIPJ0332M |
|
DIN No.: |
00283481 |
|
|
|
|
Name : |
Mr. Prem Kumar Arora |
|
Designation : |
Whole-time director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi-110052, India |
|
Date of Birth/Age : |
11.09.1938 |
|
Date of Appointment : |
01.05.2006 |
|
DIN No.: |
00704226 |
|
|
|
|
Name : |
Mrs. Sheetal Arora |
|
Designation : |
Whole-time director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi-110052, India |
|
Date of Birth/Age : |
18.11.1975 |
|
Date of Appointment : |
21.09.2007 |
|
DIN No.: |
00704292 |
|
|
|
|
Name : |
Mr. Arjun Juneja |
|
Designation : |
Whole-time director |
|
Address : |
B-7, Vasant Marg, 2nd Floor, Vasant Vihar, New
Delhi-110057, India |
|
Date of Birth/Age : |
09.05.1986 |
|
Date of Appointment : |
30.09.2009 |
|
PAN No.: |
AGEPJ3227A |
|
DIN No.: |
00704349 |
|
|
|
|
Name : |
Mr. Sanjiv Dwarkanath Kaul |
|
Designation : |
Director |
|
Address : |
22, Siris Road, DLF Qutab Enclave, Phase-3, Gurgaon – 122002, Haryana,
India |
|
Date of Birth/Age : |
25.07.1957 |
|
Date of Appointment : |
24.04.2007 |
|
DIN No.: |
01550413 |
|
|
|
|
Name : |
Prabha Arora |
|
Designation : |
Director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi - 110052, India |
|
Date of Birth/Age : |
07.07.1948 |
|
Date of Appointment : |
06.02.1995 |
|
PAN No.: |
ADPPA3875K |
|
DIN No.: |
00283527 |
|
|
|
|
Name : |
Mr. Puja Juneja |
|
Designation : |
Director |
|
Address : |
C-4/2, 1st Floor, Safdarjung Development Area, New
Delhi-110029, India |
|
Date of Birth/Age : |
20.02.1973 |
|
Date of Appointment : |
01.05.2006 |
|
PAN No.: |
ADIPJ0330K |
|
DIN No.: |
00504198 |
KEY EXECUTIVES
|
Name : |
Mr. Sanjeev Kumar Singh |
|
Designation : |
Secretary |
|
Address : |
2531 (A), 1st Floor, Housing Road, Sector – 3, Faridabad –
121004, Haryana, India |
|
Date of Birth/Age : |
10.05.1976 |
|
Date of Appointment : |
01.08.2006 |
|
PAN No.: |
AVWPS0513P |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2012
|
Names of Shareholders |
No. of Shares |
|
Ramesh Chand Juneja |
400588 |
|
Rajeev Juneja |
4686779 |
|
Puja Juneja |
1195861 |
|
Prabha Arora |
4988176 |
|
Poonam Juneja |
943385 |
|
P K Arora |
3156 |
|
Arjun Juneja |
5608240 |
|
Monet Limited |
2157534 |
|
Dinaz Kaul |
45703 |
|
|
|
|
Total |
20029422 |
AS ON 29.09.2012
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
89.00 |
|
Other
top fifty shareholders |
|
10.77 |
|
Others
|
|
0.23 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Trader of Pharmaceutical and Health Care Products. |
||||
|
|
|
||||
|
Products : |
|
PRODUCTION STATUS (AS ON 31.03.2011)
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
Filled Liquid Injectibles |
(Nos.)/ P.A |
N.A. |
900 lacs |
746.21 lacs |
|
Dry Powder Injectibles |
(Nos.)/ P.A |
N.A. |
360 lacs |
68.93 lacs |
|
Tablets & Capsules |
(Nos.)/ P.A |
N.A. |
12000 lacs |
377.80 lacs |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||||||||
|
|
|
|||||||||||||||
|
Bankers : |
ICICI Bank Limited,
Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India |
|||||||||||||||
|
|
|
|||||||||||||||
|
Facilities : |
|
|||||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Bhagi Bhardwaj
Gaur and Company Chartered Accountants |
|
Address : |
2952-53/2,
Sangtrashan, D.B Gupta Road, Paharganj, New Delhi-110055, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AADFB8409K |
|
|
|
|
Subsidiaries : |
Ř Prolijune Life
Sciences Private Limited Ř Magnet Labs
Private Limited
[U51397DL1998PTC093307] Ř Life Star Pharma
Limited [U24232DL2004PTC131232] Ř Broadway
Hospitality Private Limited [U85110DL2003PTC123280] Ř Casablanca
Industries Private Limited |
|
|
|
|
Other Related Party : |
Rashi Apparels
Private Limited |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25,000,000 |
Equity Shares |
Rs. 10/- each |
Rs. 250.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
20,029,422 |
Equity Shares |
Rs. 10/- each |
Rs. 200.294
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
200.294 |
200.294 |
148.366 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
9006.892 |
6866.961 |
4849.989 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
9207.186 |
7067.255 |
4998.355 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
7.998 |
37.089 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.000 |
7.998 |
37.089 |
|
|
DEFERRED TAX LIABILITIES |
64.003 |
18.901 |
20.722 |
|
|
|
|
|
|
|
|
TOTAL |
9271.189 |
7094.154 |
5056.166 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1778.063 |
777.323 |
846.183 |
|
|
Capital work-in-progress |
3.441 |
149.747 |
73.020 |
|
|
|
|
|
|
|
|
INVESTMENT |
1761.597 |
2596.930 |
1564.187 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
3617.345
|
2719.254 |
1535.523
|
|
|
Sundry Debtors |
1397.351
|
1133.983 |
932.974
|
|
|
Cash & Bank Balances |
891.518
|
834.125 |
995.544
|
|
|
Other Current Assets |
670.546
|
501.622 |
0.000
|
|
|
Loans & Advances |
4077.561
|
2255.929 |
1441.160
|
|
Total
Current Assets |
10654.321
|
7444.913 |
4905.201 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
2062.725
|
1578.797 |
994.853
|
|
|
Other Current Liabilities |
652.337
|
658.314 |
547.713
|
|
|
Provisions |
2211.171
|
1637.648 |
789.859
|
|
Total
Current Liabilities |
4926.233
|
3874.759 |
2332.425
|
|
|
Net Current Assets |
5728.088
|
3570.154 |
2572.776
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
9271.189 |
7094.154 |
5056.166 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from operations |
16505.748 |
14068.803 |
10857.716 |
|
|
|
Other Income |
339.604 |
238.415 |
196.777 |
|
|
|
TOTAL (A) |
16845.352 |
14307.218 |
11054.493 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of materials consumed |
618.361 |
441.747 |
296.455 |
|
|
|
Purchases of stock-in-trade |
7740.726 |
6991.938 |
4732.987 |
|
|
|
Changes in inventories
of finished goods, work-in-progress and stock-in-trade |
(774.052) |
(1068.392) |
(50.268) |
|
|
|
Employee benefit
expense |
2370.245 |
1881.841 |
1399.436 |
|
|
|
Other expenses |
3979.598 |
3083.014 |
2121.690 |
|
|
|
TOTAL (B) |
13934.878 |
11330.148 |
8500.300 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
2910.474 |
2977.070 |
2554.193 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
13.502 |
13.610 |
15.165 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
2896.972 |
2963.460 |
2539.028 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
114.713 |
77.581 |
44.414 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
2782.259 |
2885.879 |
2494.614 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
645.320 |
816.978 |
774.426 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
2136.939 |
2068.901 |
1720.188 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’ BALANCE
BROUGHT FORWARD |
5586.324 |
3724.313 |
2236.897 |
|
|
|
|
|
|
|
|
|
|
Amounts transferred reserves |
0.009 |
51.928 |
0.000 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
213.694 |
206.890 |
172.019 |
|
|
|
Final Dividend |
0.000 |
0.000 |
8.825 |
|
|
|
Interim Dividend |
0.000 |
0.000 |
51.928 |
|
|
|
Tax on Dividend |
0.000 |
0.000 |
0.000 |
|
|
BALANCE CARRIED
TO THE B/S |
7509.560 |
5586.324 |
3724.313 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
|
|
Sales of FOB Basis |
7.448 |
13.877 |
0.000 |
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
|
|
0.000 |
6.873 |
|
|
|
Machinery and Equipments |
|
0.879 |
21.203 |
|
|
TOTAL IMPORTS |
N.A. |
0.879 |
28.076 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
106.69 |
114.70 |
95.37 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
12.69
|
14.46 |
15.56 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
16.86
|
20.51 |
22.98 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
22.38
|
35.10 |
43.37 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.30
|
0.41 |
0.50 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.00
|
0.00 |
0.01 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.16
|
1.92 |
2.10 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
CORPORATE
INFORMATION:
Mankind Pharma
Limited (the 'Company') is a public limited company domiciled in India. The company
is engaged in the manufacturing and trading of pharmaceutical and health care
products. The company has manufacturing facilities in Himachal Pradesh and
Research and Development centre in Manesar. The products of the company have
pan India presence and are also being exported to some Asian countries.
MANAGEMENT
DISCUSSION AND ANALYSIS
In the year the
Company has recorded an impressive growth by scaling newer heights and
benchmarks in terms of sales. The Gross Revenue generated during the year ended
March 31, 2012 increased by more than 17% and touched the level Rs. 16505.700
Millions as against average growth of just over 13% achieved by the Indian
Pharmaceutical industry. However, continuous surge in the various input cost as
well as rising competition from foreign companies and compulsion to lower the
sales price of certain products on account of regulatory promulgations shrinked
the margins in terms of profit before tax. However, the increased production at
company's plants located at notified areas helped the company in generating
marginally higher retained funds (BPT) than previous year. The Net Worth has
further increased by 30% during the year which affect the increase in value of
stakeholders' funds.
FIXED ASSETS:
Ř
Land
Ř
Buildings
Ř
Other building
Ř
Plant and equipment
Ř
Furniture and fixtures
Ř
Vehicles
Ř
Motor vehicles
Ř
Office equipment
Ř
Other equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or investigation
registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 54.03 |
|
|
1 |
Rs. 82.43 |
|
Euro |
1 |
Rs. 70.49 |
INFORMATION DETAILS
|
Report Prepared
by : |
BVA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
8 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
8 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTERS |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
67 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.